title: [Calcium folate in pregnancy. Therapeutic efficacy].
abstract: An open, randomised multicentre study was carried out to compare pregnant women, treated with calcium folinate (Citofolin Bracco S.p.A.) 15 mg/day per os starting from the 12th or 20th week of gestation, with an untreated group. The results obtained confirm the efficacy of calcium folinate treatment on the trends of parameters analysed (serum and endoerythrocytic folatemia, hemoglobin and sideremia) which remained within the normal range. Moreover, no adverse effects of any type were reported during the study.
authors.affiliation: Clinica Ostetrica e Ginecologica, Università degli Studi di Pavia.
authors.forename: F
authors.initials: F
authors.lastname: Polatti
authors.forename: F
authors.initials: F
authors.lastname: Perotti
authors.forename: R
authors.initials: R
authors.lastname: Nappi
authors.forename: P
authors.initials: P
authors.lastname: Prandi
mesh_terms: D002136:Calcium, Dietary / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage*; D006801:Humans; D009751:Nutritional Requirements; D011247:Pregnancy / Q000378:metabolism*; D011262:Pregnancy Trimester, Second
chemical_list: D002136:Calcium, Dietary; D005492:Folic Acid
vernacular_title: Calcio folinato in gravidanza. Efficacia terapeutica.